ARROWHEAD PHARMACEUTICALS, INC. Quarterly Other Assets, Noncurrent in USD from Q3 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2010 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $4.46M, a 2024% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $4.46M +$4.25M +2024% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $210K $0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $232K +$22K +10.5% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $3.26M +$3.04M +1395% Sep 30, 2023 10-Q 2024-08-08
Q2 2023 $210K -$65K -23.6% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $210K -$65K -23.6% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $210K -$63K -23.1% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 $218K -$54K -19.9% Sep 30, 2022 10-K 2023-11-29
Q2 2022 $275K +$3K +1.1% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $275K +$10K +3.77% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $273K +$8K +3.02% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 $272K +$8K +3.03% Sep 30, 2021 10-K 2022-11-28
Q2 2021 $272K +$6.64K +2.5% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $265K +$121K +83.8% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $265K +$121K +83.8% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $264K +$120K +83.1% Sep 30, 2020 10-K 2021-11-22
Q2 2020 $265K +$94.4K +55.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $144K +$2.23K +1.57% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $144K +$2.23K +1.57% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 $144K +$2.23K +1.57% Sep 30, 2019 10-K 2020-11-23
Q2 2019 $171K +$29K +20.4% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $142K $0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $142K $0 0% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $142K $0 0% Sep 30, 2018 10-K 2019-11-25
Q2 2018 $142K -$12.7K -8.21% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $142K -$10.2K -6.71% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $142K +$19.6K +16% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 $142K +$19.6K +16% Sep 30, 2017 10-K 2018-12-11
Q2 2017 $155K +$32.3K +26.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $152K +$29.8K +24.3% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $122K +$76.5K +167% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 $122K +$76.5K +167% Sep 30, 2016 10-K 2017-12-12
Q2 2016 $122K Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $122K Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $45.8K Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $45.8K Sep 30, 2015 10-K 2016-12-14
Q4 2013 $13.1M +$8.35M +176% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 $4.97M -$92.2K -1.82% Sep 30, 2013 10-Q 2014-02-04
Q2 2013 $3.28M -$1.94M -37.1% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 $4.67M +$148K +3.28% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $4.74M -$2.22M -31.9% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 $5.06M -$937K -15.6% Sep 30, 2012 10-K 2013-12-18
Q2 2012 $5.22M -$992K -16% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 $4.52M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 $6.96M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 $6M +$1.92M +47.1% Sep 30, 2011 10-K 2012-12-28
Q2 2011 $6.21M Jun 30, 2011 10-Q 2011-08-08
Q3 2010 $4.08M Sep 30, 2010 10-K 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.